Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
(Q39146505)
scientific article published on 28 May 2013
scientific article published on 28 May 2013
Language: